AI 채팅
Loading data for BRGX — first visit, this takes a few seconds.

BioRegenx, Inc.

BRGX · OTC Markets OTCPK · USD

0.00 -0.01 (-100.00%)

종가 기준: Sep 15, 2026, 1:45 PM

BioRegenx, Inc.(BRGX) 주가, 분석 및 데이터

내재가치

내재 가치 로딩 중…

애널리스트 전망

주가 전망 →

애널리스트 전망 없음

12개월 목표가 · 애널리스트 n/a명

애널리스트 컨센서스: n/a

간격:1D
캔들과 신호 불러오는 중…

재무 실적

재무 정보 보기 →

불러오는 중...

최근 실적

발표치예상 대비전년 대비
매출n/an/a
EPSn/an/a

다음 실적 발표

실적 상세 보기 →

지표

매수호가
0.01
순이익 (ttm)
-1.3M
-2.71
0
n/a
n/a
P/B (ttm)
-0.90
P/S (ttm)
2.48
실적 발표일
n/a
매도호가
0.01
거래량
100,000
평균 거래량 (20일)
23,667
시가
0.00
전일 종가
0.01
일중 범위
0.00 - 0.00
52주 범위
0.00 - 0.03
배당
n/a
배당락일
n/a
아직 등록된 뉴스가 없습니다

BioRegenx, Inc. 소개

기업 정보 보기 →
BioRegenx, Inc. engages in the research, development, and commercialization of dietary supplements, medical devices, software, and contactless diagnostic technologies in the United States and internationally. The company offers DocSun AI engine, which integrates with a ballistocardiograph that detects an individual's heartbeat; TruScan.AI mobile app for additional health indications; VitalWellness app for DNA and epigenetics platform; and Endocalyx Pro, a dietary supplement targeting microvascular capillary health. It also provides MyBodyRx, a supplement; GlycoCheck software and medical devices; hydrogen water products and health and wellness devices, such as pulsed electro-magnetic field devices; StimaWELL and ReLounge electronic muscle stimulation therapy devices; and Findit.com, a social media content management platform. The company sells its products through a direct selling channel to health professionals and research organizations. BioRegenx, Inc. is headquartered in Chattanooga, Tennessee. Health Information Services · Healthcare

BioRegenx, Inc. engages in the research, development, and commercialization of dietary supplements, medical devices, software, and contactless diagnostic technologies in the United States and internationally. The company offers DocSun AI engine, which integrates with a ballistocardiograph that detects an individual's heartbeat; TruScan.AI mobile app for additional health indications; VitalWellness app for DNA and epigenetics platform; and Endocalyx Pro, a dietary supplement targeting microvascular capillary health. It also provides MyBodyRx, a supplement; GlycoCheck software and medical devices; hydrogen water products and health and wellness devices, such as pulsed electro-magnetic field devices; StimaWELL and ReLounge electronic muscle stimulation therapy devices; and Findit.com, a social media content management platform. The company sells its products through a direct selling channel to health professionals and research organizations. BioRegenx, Inc. is headquartered in Chattanooga, Tennessee.

섹터 Healthcare
IPO 일자 Feb 15, 2002
직원 수 6
상장 거래소 OTC Markets OTCPK
티커 BRGX